Us Bancorp \De\ Amicus Therapeutics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 12,016 shares of FOLD stock, worth $113,070. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,016

Previous 24,862 51.67%

Holding current value

$113,070

Previous $246,000 47.97%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$9.55 - $12.09 $122,679 - $155,308	-12,846 Reduced 51.67%	12,016 $128,000
Q2 2024 Aug 06, 2024	BUY	$9.04 - $11.75 $8,895 - $11,562	984 Added 4.12%	24,862 $246,000
Q1 2024 May 07, 2024	SELL	$11.43 - $14.24 $37,901 - $47,219	-3,316 Reduced 12.19%	23,878 $281,000
Q4 2023 Feb 09, 2024	BUY	$9.97 - $14.52 $35,802 - $52,141	3,591 Added 15.21%	27,194 $385,000
Q3 2023 Nov 03, 2023	SELL	$11.78 - $13.86 $8,316 - $9,785	-706 Reduced 2.9%	23,603 $287,000
Q2 2023 Aug 09, 2023	SELL	$10.72 - $13.3 $91,806 - $113,901	-8,564 Reduced 26.05%	24,309 $305,000
Q1 2023 May 09, 2023	BUY	$10.91 - $13.54 $19,768 - $24,534	1,812 Added 5.83%	32,873 $364,000
Q4 2022 Feb 13, 2023	SELL	$9.89 - $12.7 $163,165 - $209,524	-16,498 Reduced 34.69%	31,061 $379,000
Q3 2022 Oct 27, 2022	SELL	$9.82 - $12.75 $17,018 - $22,095	-1,733 Reduced 3.52%	47,559 $498,000
Q2 2022 Aug 01, 2022	BUY	$6.23 - $11.12 $213,333 - $380,782	34,243 Added 227.54%	49,292 $529,000
Q1 2022 May 11, 2022	BUY	$7.89 - $12.48 $118,034 - $186,700	14,960 Added 16808.99%	15,049 $143,000
Q4 2021 Feb 11, 2022	SELL	$9.82 - $12.44 $106,232 - $134,575	-10,818 Reduced 99.18%	89 $1,000
Q3 2021 Nov 10, 2021	SELL	$8.74 - $11.84 $19,883 - $26,936	-2,275 Reduced 17.26%	10,907 $104,000
Q2 2021 Aug 05, 2021	BUY	$8.71 - $10.72 $17,028 - $20,957	1,955 Added 17.41%	13,182 $127,000
Q1 2021 Apr 28, 2021	BUY	$9.2 - $23.86 $100,344 - $260,241	10,907 Added 3408.44%	11,227 $111,000
Q4 2020 Feb 04, 2021	BUY	$13.47 - $24.89 $1,495 - $2,762	111 Added 53.11%	320 $7,000
Q2 2020 Aug 07, 2020	SELL	$8.86 - $15.69 $1,940 - $3,436	-219 Reduced 51.17%	209 $3,000
Q1 2020 May 13, 2020	SELL	$6.63 - $11.16 $1,160 - $1,953	-175 Reduced 29.02%	428 $4,000
Q4 2019 Feb 04, 2020	BUY	$7.48 - $10.75 $4,510 - $6,482	603 New	603 $6,000
Q3 2019 Nov 08, 2019	SELL	$8.02 - $13.25 $39,265 - $64,872	-4,896 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$10.96 - $14.4 $18,094 - $23,774	1,651 Added 50.88%	4,896 $61,000
Q1 2019 May 08, 2019	BUY	$10.04 - $13.92 $25,581 - $35,468	2,548 Added 365.57%	3,245 $44,000
Q4 2018 Feb 13, 2019	BUY	$8.38 - $13.44 $5,840 - $9,367	697 New	697 $7,000
Q2 2018 Aug 08, 2018	SELL	$13.13 - $17.09 $10,687 - $13,911	-814 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$13.76 - $17.12 $41 - $51	-3 Reduced 0.37%	814 $12,000
Q4 2017 Feb 02, 2018	BUY	$12.51 - $16.24 $50 - $64	4 Added 0.49%	817 $12,000
Q3 2017 Nov 13, 2017	BUY	$11.74 - $15.78 $9,544 - $12,829	813	813 $12,000

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

312M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.64B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account